Physician profile
Sandra E Collazo
NPI 1659447928
$2,821.45
in general payments reported to CMS, 2019-2025
18 companies · $728 in 2025
The $728 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $61.66 · 2021: $194 · 2022: $462 · 2023: $273 · 2024: $688 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $474.55 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $467.28 | 2023-2025 | Miebo, Xiidra |
| Oyster Point Pharma, INC. | $324.54 | 2022-2024 | Tyrvaya |
| Glaukos Corporation | $306.24 | 2024-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Alcon Vision LLC | $218.67 | 2019-2025 | Argos, Eysuvis, Tryptyr |
| Novartis Pharmaceuticals Corporation | $199.99 | 2019-2022 | |
| Allergan, INC. | $165.03 | 2019-2021 | |
| Dompe US, INC. | $154.05 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $112.21 | 2021 | |
| Rxsight INC | $105.62 | 2022 | |
| Shire North American Group INC | $102.44 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $49.79 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $47.41 | 2023-2025 | Cystadrops |
| Sight Sciences, INC. | $25.17 | 2024 | Tearcare System |
| Eyevance Pharmaceuticals LLC | $22.53 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $17.50 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Bausch Health US, LLC | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Collazo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.